United States · FDA National Drug Code directory
INZIRQO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-522_d6ace9b2-f8fa-42b9-8338-9e2b5519ef6b
- Product NDC
- 70954-522
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- hydrochlorothiazide
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250130
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 80 mL in 1 BOTTLE (70954-522-10) · 70954-522-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →